ArticlePloS one2022

Influence of precedent drug on the subsequent therapy in the sequence of trifluridine/tipiracil with/out bevacizumab and regorafenib for unresectable or recurrent colorectal cancer.

Kotoe Oshima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.